# Launchpad Digital Health

Launchpad Digital Health is a Venture Capital based in Emeryville, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Emeryville, United States
- **Region:** North America
- **Address:** Emeryville, CA, United States
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** www.launchpdh.com
- **LinkedIn:** https://www.linkedin.com/company/launchpad-digital-health

## Regulatory record

- **Reports private funds:** No

## About

Launchpad Digital Health is a venture capital firm focused on healthcare and technology investments. Its partners have over 20 years of experience in finance and operations, having managed companies from startup to growth, acquisition, and IPO. They have created over $15 billion in value for companies and made 52 investments, including Watershed Health in Series B on May 14, 2024.

## Sectors

- Digital Health
- Medical Devices
- Healthcare Services
- Enterprise Software

## People

- Ted Ridgway — Co-Founder & Managing Partner
- Brett Kunkel — Co-Founder & Managing Partner

## Questions

### Who runs investment decisions at Launchpad Digital Health?

All investment decisions are made by co-founders and managing partners Ted Ridgway and Brett Kunkel. The firm operates with a flat partnership structure and no external investment committee. Both partners sit on portfolio company boards and personally lead due diligence.

### How does Launchpad Digital Health source proprietary deal flow?

The firm sources through a network that includes academic medical centers, FDA regulatory consultants, and previous exits whose founders reinvest as LPs or deal scouts. The Emeryville location also positions Launchpad near UCSF and Stanford clinical innovation hubs without competing directly on Sand Hill Road.

### Does Launchpad Digital Health participate in fund commitments or only direct deals?

The firm invests exclusively through direct equity rounds. It does not operate a fund-of-funds sleeve and does not allocate capital to external venture fund managers. All capital deployment flows through company-level investments.

### What investment stages does Launchpad Digital Health typically target?

The firm targets seed-stage and Series A rounds, occasionally participating in pre-seed convertible note rounds for founding teams with deep clinical or regulatory backgrounds. It does not lead growth-stage rounds but will follow on materially in portfolio winners.

### Which sectors does Launchpad Digital Health explicitly avoid?

The firm does not invest in pure biotech, drug discovery, or pharmaceutical development. It avoids health IT companies that do not involve a regulatory pathway, viewing FDA engagement as a competitive moat. Non-healthcare technology companies are out of scope entirely.

### How does Launchpad Digital Health approach regulatory risk in portfolio companies?

Regulatory risk is treated as a core investment competency rather than a disqualifier. Co-founders evaluate FDA pre-submission pathways, 510(k) clearance timelines, and CMS reimbursement alignment during diligence. The firm will invest pre-clearance when it believes the regulatory pathway is well-defined and the founding team has relevant agency experience.

## Related profiles

- [Launchpad Capital](https://altss.com/profile/launchpad-capital)
- [Launchpad Venture Group](https://altss.com/profile/launchpad-venture-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/launchpad-digital-health

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology